Anti-tafazzin, phospholipid-lysophospholipid transacylase antibodies are used for the immunodetection of the protein encoded by the TAFAZZIN gene. In humans, the canonical protein has a reported length of 262 amino acid residues and a mass of 30.2 kDa. Alternative splicing is reported to yield 9 different isoforms for this protein. It is notably expressed in cardiac and skeletal muscle. A member of the Taffazin protein family, it is known to be involved with cardiac tissue development. The gene encoding this protein is implicated in Barth syndrome. Other names for this target antigen include CMD3A, EFE, EFE2, G4.5, LVNCX, TAZ, Taz1, and BTHS. Gene orthologs have been identified in the mouse, rat, bovine, frog, zebrafish and chimpanzee species.